RINALDI, MATTEO
RINALDI, MATTEO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Ricercatori a tempo determinato
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
2024 Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study
2024 D'Amico F.; Rinaldi M.; Pascale R.; Fabbrini M.; Morelli M.C.; Siniscalchi A.; Laici C.; Coladonato S.; Ravaioli M.; Cescon M.; Ambretti S.; Viale P.; Brigidi P.; Turroni S.; Giannella M.
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study
2024 Rinaldi, Matteo; Gatti, Milo; Tonetti, Tommaso; Nocera, Domenico; Ambretti, Simone; Berlingeri, Andrea; Nigrisoli, Giacomo; Pierucci, Elisabetta; Siniscalchi, Antonio; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena
Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study
2024 Rinaldi, Matteo; Gatti, Milo; Tonetti, Tommaso; Nocera, Domenico; Ambretti, Simone; Berlingeri, Andrea; Nigrisoli, Giacomo; Pierucci, Elisabetta; Siniscalchi, Antonio; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment
2024 Amadesi S.; Gatti M.; Rinaldi M.; Pea F.; Viale P.; Gaibani P.
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria
2024 Bonazzetti, Cecilia; Rinaldi, Matteo; Cosentino, Federica; Gatti, Milo; Freire, Maristela Pinheiro; Mularoni, Alessandra; Clemente, Wanessa Trindade; Pierrotti, Ligia Camera; Aguado, Jose Maria; Grossi, Paolo; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF)
2023 Gatti M.; Rinaldi M.; Gaibani P.; Siniscalchi A.; Tonetti T.; Giannella M.; Viale P.; Pea F.
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia
2023 Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia
2023 Gatti, Milo; Rinaldi, Matteo; Gaibani, Paolo; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico
Antimicrobial Resistance in Organ Transplant Recipients
2023 Giannella M.; Rinaldi M.; Viale P.
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study
2023 Rinaldi M.; Campoli C.; Gallo M.; Marzolla D.; Zuppiroli A.; Riccardi R.; Casarini M.; Riccucci D.; Malosso M.; Bonazzetti C.; Pascale R.; Tazza B.; Pasquini Z.; Marconi L.; Curti S.; Giannella M.; Viale P.
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?
2023 Gatti, Milo; Rinaldi, Matteo; Bonazzetti, Cecilia; Gaibani, Paolo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia?
2023 Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?
2023 Gatti, Milo; Rinaldi, Matteo; Potena, Luciano; Salvaterra, Elena; Morelli, Maria Cristina; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis
2023 Gatti, Milo; Bonazzetti, Cecilia; Tazza, Beatrice; Pascale, Renato; Miani, Beatrice; Malosso, Marta; Beci, Giacomo; Marzolla, Domenico; Rinaldi, Matteo; Viale, Pierluigi; Giannella, Maddalena
Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
2023 Troisi, Carla; Cojutti, Pier Giorgio; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection: due to OXA-181-producing Klebsiella pneumoniae
2023 Gatti, Milo; Rinaldi, Matteo; Gaibani, Paolo; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
2023 Berrino, Pasquale Maria; Gatti, Milo; Rinaldi, Matteo; Brunocilla, Eugenio; Viale, Pierluigi; Pea, Federico
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)
2023 Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Gaibani, Paolo; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration
2023 Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico